Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
ACX-362E
Parent topics
New and investigational antibiotics
Oral antibiotics
This topic
Recent activity
You must be
signed in
to add and move topics and links.
Acurx Receives USAN Approval of Non-proprietary Name Ibezapolstat for Its Phase 2 Novel, First-in-Class Antibiotic for C. difficile Infection | State | oleantimesherald.com
http://www.oleantimesherald.com/news/state/acurx-receives-usan-approval-of-non-proprietary-name-ibezapolstat-for/article_fae8ebe2-48ff-5609-abae-37ab670f9d0f.html
ACX-362E
Acurx Successfully Completes Ph1 Clinical Trial for ACX-362E in CDI
https://www.prnewswire.com/news-releases/acurx-successfully-completes-ph1-clinical-trial-for-acx-362e-in-cdi-300908613.html
ACX-362E
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Acurx's Novel Lead Antibiotic Candidate Presented at Two Prominent International Scientific Conferences
https://www.prnewswire.com/news-releases/acurxs-novel-lead-antibiotic-candidate-presented-at-two-prominent-international-scientific-conferences-300930932.html
ACX-362E